Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival
David M. Gershenson, Lauren Cobb, Shannon N. Westin, Yingao Zhang, Amir A. Jazaeri, Anaís Malpica, Charlotte C. Sun
Topics & Concepts
MedicineInternal medicineProportional hazards modelOvarian cancerCohortSerous fluidTaxaneSurgeryStage (stratigraphy)Aromatase inhibitorProgression-free survivalGastroenterologyCancerChemotherapyOncologyBreast cancerAromataseBiologyPaleontologyOvarian cancer diagnosis and treatmentIntraperitoneal and Appendiceal MalignanciesPARP inhibition in cancer therapy